139 related articles for article (PubMed ID: 18778970)
1. Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy.
Watkins JM; Harper JL; Dragun AE; Ashenafi MS; Sinha D; Li J; Cole DJ; Jenrette JM
Brachytherapy; 2008; 7(4):305-9. PubMed ID: 18778970
[TBL] [Abstract][Full Text] [Related]
2. Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: incidence, pathologic anatomy, and contributing factors.
Evans SB; Kaufman SA; Price LL; Cardarelli G; Dipetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):333-9. PubMed ID: 16545918
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative placement of MammoSite for breast brachytherapy treatment and seroma incidence.
Ravi A; Lee S; Karsif K; Osian A; Nori D
Brachytherapy; 2010; 9(1):76-80. PubMed ID: 19853537
[TBL] [Abstract][Full Text] [Related]
4. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
[TBL] [Abstract][Full Text] [Related]
5. Permanent breast seed implant for partial breast radiotherapy after partial mastectomy for favorable breast cancer: Technique, results, and applications to various seroma presentations.
Crook J; Hilts M; Batchelar D; Milette MP; Kozeniowski M; Pilote L; Pignol JP
Brachytherapy; 2019; 18(4):510-520. PubMed ID: 31109871
[TBL] [Abstract][Full Text] [Related]
6. Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up.
Dragun AE; Harper JL; Jenrette JM; Sinha D; Cole DJ
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):354-8. PubMed ID: 17383829
[TBL] [Abstract][Full Text] [Related]
7. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
8. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence.
Trombetta M; Hall M; Julian TB
Brachytherapy; 2014; 13(5):488-92. PubMed ID: 24950822
[TBL] [Abstract][Full Text] [Related]
9. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
[TBL] [Abstract][Full Text] [Related]
10. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
[TBL] [Abstract][Full Text] [Related]
11. Interfraction accumulation of seroma during accelerated partial breast irradiation: preliminary results of a prospective study.
Bhatt AD; Crew JB; Bhatt G; Johnson RR; Sowards KT; Pan J; Dragun AE
Brachytherapy; 2012; 11(5):374-9. PubMed ID: 21820365
[TBL] [Abstract][Full Text] [Related]
12. A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer.
Hieken TJ; Mutter RW; Jakub JW; Boughey JC; Degnim AC; Sukov WR; Childs S; Corbin KS; Furutani KM; Whitaker TJ; Park SS
Ann Surg Oncol; 2016 Oct; 23(10):3297-303. PubMed ID: 27334215
[TBL] [Abstract][Full Text] [Related]
13. Seroma is an expected consequence and not a complication of MammoSite brachytherapy.
Patel PS; Yan W; Trichter S; Sabbas A; Rosenblatt R; Drotman MB; Swistel A; Chao KS; Nori D; Hayes MK
Breast J; 2011; 17(5):498-502. PubMed ID: 21827558
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial.
Niehoff P; Polgár C; Ostertag H; Major T; Sulyok Z; Kimmig B; Kovács G
Radiother Oncol; 2006 Jun; 79(3):316-20. PubMed ID: 16780977
[TBL] [Abstract][Full Text] [Related]
15. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
[TBL] [Abstract][Full Text] [Related]
16. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
[TBL] [Abstract][Full Text] [Related]
17. Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy registry trial.
Khan AJ; Arthur D; Vicini F; Beitsch P; Kuerer H; Goyal S; Lyden M; Haffty BG
Ann Surg Oncol; 2012 May; 19(5):1477-83. PubMed ID: 22109731
[TBL] [Abstract][Full Text] [Related]
18. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
[TBL] [Abstract][Full Text] [Related]
19. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy.
Stecklein SR; Shaitelman SF; Babiera GV; Bedrosian I; Black DM; Ballo MT; Arzu I; Strom EA; Reed VK; Dvorak T; Smith BD; Woodward WA; Hoffman KE; Schlembach PJ; Kirsner SM; Nelson CL; Yang J; Guerra W; Dibaj S; Bloom ES
Pract Radiat Oncol; 2019 Jan; 9(1):e4-e13. PubMed ID: 30125673
[TBL] [Abstract][Full Text] [Related]
20. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.
Jeruss JS; Vicini FA; Beitsch PD; Haffty BG; Quiet CA; Zannis VJ; Keleher AJ; Garcia DM; Snider HC; Gittleman MA; Whitacre E; Whitworth PW; Fine RE; Arrambide S; Kuerer HM
Ann Surg Oncol; 2006 Jul; 13(7):967-76. PubMed ID: 16788759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
